Skip Navigation

Cardiovascular Research 2007 73(2):348-358; doi:10.1016/j.cardiores.2006.08.022
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stangl, V.
Right arrow Articles by Lorenz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stangl, V.
Right arrow Articles by Lorenz, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Molecular targets of tea polyphenols in the cardiovascular system

Verena Stangl*, Henryk Dreger, Karl Stangl and Mario Lorenz

Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie Charité – Universitätsmedizin Berlin, CCM, Schumannstr. 20-21, D-10117 Berlin, Germany

* Corresponding author. Tel.: +49 30 450 513153; fax: +49 30 450 513932. Email address: verena.stangl{at}charite.de

Tea-derived polyphenols have attracted considerable attention in the prevention of cancer and cardiovascular diseases. In comparison to tumour cells, the elucidation of their molecular targets in cardiovascular relevant cells is still at the beginning. Although promising experimental and clinical data demonstrate protective effects for the cardiovascular system, little information is actually available on how these beneficial effects of tea polyphenols are mediated at the cellular level. By affecting the activity of receptor and signal transduction kinases, both catechins and theaflavins – the major ingredients of green and black tea, respectively – exert a variety of cardiovascular beneficial effects. In general, the number and positions of galloyl groups have major influence on the potency of polyphenols. Compared to their broad impact on cellular signal transduction, tea polyphenols reveal little transcriptional effects. However, more detailed and profound analysis of molecular actions in different cells of the cardiovascular system is necessary before safe clinical use of tea polyphenols for treatment of cardiovascular diseases will become possible.

KEYWORDS Tea; Polyphenols; Catechins; Theaflavins; Cardiovascular; Atherosclerosis; Molecular


Time for primary review 27 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H. M. Piper, D. Garcia-Dorado, and E. A. Martinson
Monitoring the success of articles: a look back and a look ahead
Cardiovasc Res, December 1, 2008; 80(3): 321 - 323.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Lorenz, N. Hellige, P. Rieder, H.-T. Kinkel, C. Trimpert, A. Staudt, S. B. Felix, G. Baumann, K. Stangl, and V. Stangl
Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers
Eur J Heart Fail, May 1, 2008; 10(5): 439 - 445.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
H. Dreger, M. Lorenz, A. Kehrer, G. Baumann, K. Stangl, and V. Stangl
Characteristics of Catechin- and Theaflavin-Mediated Cardioprotection
Experimental Biology and Medicine, April 1, 2008; 233(4): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. Wolfram
Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health
J. Am. Coll. Nutr., August 1, 2007; 26(4): 373S - 388S.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. E. Mann, D. J. Rowlands, F. Y.L. Li, P. de Winter, and R. C.M. Siow
Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression
Cardiovasc Res, July 15, 2007; 75(2): 261 - 274.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Napoli, W. C. Stanley, and L. J. Ignarro
Nutrition and cardiovascular disease: Putting a pathogenic framework into focus
Cardiovasc Res, January 15, 2007; 73(2): 253 - 256.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Yamada and H. Watanabe
Tea polyphenols in preventing cardiovascular diseases
Cardiovasc Res, January 15, 2007; 73(2): 439 - 440.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.